Amlodipine/Metoprolol

氨氯地平/美托洛尔

Report date: 2022/03/08 16:46:54

Base Information

Drug NameAmlodipine/Metoprolol
Drug Alias NameAmlodipine+Metoprolol XLMetoprolol/AmlodipineMetoprolol+AmlodipineSelomax
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptorsVoltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC07FB13
Related LinksN/A